Il y a eu 50 transactions d'initiés récentes enregistrées pour IntelGenx Technologies Corp. (IGXT), dont 34 achats et 16 ventes. Le total des achats d'initiés s'élève à $2.47M et le total des ventes d'initiés à $258.48K.
Les initiés notables ayant une activité récente comprennent Pourhassan Zenoz Nina, Kideckel David, Kalayajian Karen. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — IGXT
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2027-04-04 |
Pourhassan Zenoz Nina |
VP, Quality Ops of Subsidiary |
Cession |
6,250 |
$0.19 |
$1.19K |
- |
| 2027-04-04 |
Kideckel David |
SVP, Corp. Dev&sa - Subsidiary |
Cession |
62,500 |
$0.19 |
$11.88K |
- |
| 2027-01-29 |
Kalayajian Karen |
VP, Finance&admin - Subsidiary |
Cession |
6,250 |
$0.24 |
$1.5K |
- |
| 2026-04-04 |
Pourhassan Zenoz Nina |
VP, Quality Ops of Subsidiary |
Cession |
6,250 |
$0.19 |
$1.19K |
- |
| 2025-06-30 |
Gorham Dwight |
CEO |
Cession |
950,000 |
$0.16 |
$152K |
- |
| 2025-04-04 |
Kalayajian Karen |
VP, Finance&admin - Subsidiary |
Cession |
12,500 |
$0.19 |
$2.38K |
- |
| 2024-04-19 |
Atai Life Sciences N.v. |
10 Percent Owner |
Autre (Achat) |
- |
$0.19 |
- |
- |
| 2024-03-08 |
Atai Life Sciences N.v. |
10 Percent Owner |
Autre (Achat) |
4,000,000 |
$0.17 |
$680K |
4,000,000 |
| 2024-01-29 |
Zerbe Horst G |
Director |
Attribution de RSU |
107,435 |
- |
- |
138,204 |
| 2024-01-29 |
Melchers Bernd Josef |
Director |
Attribution de RSU |
111,783 |
- |
- |
111,783 |
| 2024-01-29 |
Godin Andre |
President and CFO |
Attribution de RSU |
163,968 |
- |
- |
387,045 |
| 2024-01-29 |
Mayr Clemens |
Director |
Attribution de RSU |
92,510 |
- |
- |
111,783 |
| 2024-01-29 |
Paiement Nadine |
VP R & D of Intelgenx Corp. |
Attribution de RSU |
96,206 |
- |
- |
136,206 |
| 2024-01-29 |
Nawacki Mark |
Director |
Attribution de RSU |
111,783 |
- |
- |
111,783 |
| 2024-01-29 |
Kenny Tommy |
SVP Ip Legal Affairs Subsid |
Attribution de RSU |
95,648 |
- |
- |
145,648 |
| 2024-01-29 |
Kalayajian Karen |
VP, Finance & Admin of Subs. |
Attribution de RSU |
97,925 |
- |
- |
137,925 |
| 2024-01-29 |
Gorham Dwight |
CEO |
Attribution de RSU |
182,186 |
- |
- |
182,186 |
| 2024-01-29 |
Pourhassan Zenoz Nina |
VP, Quality Operations of Subs |
Attribution de RSU |
67,682 |
- |
- |
67,682 |
| 2023-12-10 |
Kalayajian Karen |
VP, Finance&admin - Subsidiary |
Cession |
25,000 |
$0.44 |
$11K |
- |
| 2023-11-28 |
Atai Life Sciences N.v. |
10 Percent Owner |
Achat Informatif |
750,000 |
$0.19 |
$138.75K |
2,970,000 |
| 2023-10-06 |
Atai Life Sciences N.v. |
10 Percent Owner |
Autre (Achat) |
8,500,000 |
$0.19 |
$1.57M |
8,500,000 |
| 2023-09-30 |
Atai Life Sciences N.v. |
10 Percent Owner |
Autre (Achat) |
7,401 |
- |
- |
7,401 |
| 2023-08-31 |
Atai Life Sciences N.v. |
10 Percent Owner |
Achat Informatif |
- |
$0.19 |
- |
- |
| 2023-04-13 |
Kalayajian Karen |
VP, Finance&admin - Subsidiary |
Cession |
40,000 |
- |
- |
- |
| 2023-04-04 |
Godin Andre |
President & CFO |
Attribution de RSU |
100,000 |
$0.19 |
$19K |
223,077 |
| 2023-04-04 |
Kenny Tommy |
VP Ip Legal Affairs-subsidiary |
Attribution de RSU |
12,500 |
$0.19 |
$2.38K |
262,500 |
| 2023-04-04 |
Kideckel David |
SVP, Corp. Dev&sa - Subsidiary |
Cession |
50,000 |
- |
- |
- |
| 2023-01-29 |
Zerbe Horst G |
Chief Executive Officer |
Attribution de RSU |
125,000 |
- |
- |
155,769 |
| 2023-01-29 |
Zerbe Ingrid |
Corporate Secretary |
Attribution de RSU |
6,250 |
$0.24 |
$1.5K |
6,250 |
| 2023-01-29 |
Godin Andre |
President & CFO |
Attribution de RSU |
100,000 |
- |
- |
123,077 |
| 2023-01-29 |
Paiement Nadine |
VP R & D, Intelgenx Corp. |
Attribution de RSU |
40,000 |
- |
- |
40,000 |
| 2023-01-29 |
Matzen Dana |
VP Business & Corp. Dev |
Attribution de RSU |
50,000 |
- |
- |
50,000 |
| 2023-01-29 |
Kenny Tommy |
VP Ip Legal Affairs-subsidiary |
Attribution de RSU |
50,000 |
- |
- |
50,000 |
| 2023-01-11 |
Kenny Tommy |
VP Ip,lgl Affairs - Subsidiary |
Cession |
37,500 |
$0.27 |
$10.13K |
- |
| 2022-11-24 |
Kalayajian Karen |
VP, Finance&admin - Subsidiary |
Cession |
75,000 |
$0.27 |
$20.25K |
- |
| 2022-11-11 |
Pourhassan Zenoz Nina |
VP, Quality Ops of Subsidiary |
Cession |
55,000 |
$0.27 |
$14.85K |
- |
| 2022-09-30 |
Zerbe Horst G |
Chief Executive Officer |
Achat Informatif |
14,000 |
$0.12 |
$1.74K |
368,064 |
| 2022-09-29 |
Godin Andre |
President and CFO |
Achat Informatif |
5,000 |
$0.12 |
$620.00 |
308,399 |
| 2022-09-21 |
Matzen Dana |
VP Bd & Corp.dev.of Subsidiary |
Achat Informatif |
25,000 |
$0.14 |
$3.45K |
75,000 |
| 2022-07-07 |
Zerbe Ingrid |
Corporate Secretary |
Autre (Vente) |
100,000 |
$0.22 |
$22K |
- |
| 2022-07-07 |
Godin Andre |
President and CFO |
Autre (Vente) |
20,000 |
- |
- |
- |
| 2022-03-30 |
Matzen Dana |
VP Bd & Corp.dev.of Subsidiary |
Achat Informatif |
25,000 |
$0.27 |
$6.63K |
50,000 |
| 2021-07-11 |
Kenny Tommy |
VP Ip,lgl Affairs - Subsidiary |
Cession |
37,500 |
$0.27 |
$10.13K |
- |
| 2021-06-08 |
Matzen Dana |
VP Bd & Corp.dev.of Subsidiary |
Achat Informatif |
10,000 |
$0.48 |
$4.8K |
10,000 |
| 2021-05-14 |
Atai Life Sciences B.v. |
10 Percent Owner |
Cession |
- |
- |
- |
- |
| 2021-04-13 |
Matzen Dana |
VP Bd & Corp Dev of Subsidiary |
Achat Informatif |
25,000 |
$0.49 |
$12.23K |
25,000 |
| 2021-04-07 |
Godin Andre |
President and CFO |
Achat Informatif |
20,000 |
$0.44 |
$8.8K |
200,171 |
| 2021-04-07 |
Kenny Tommy |
VP Ip Legal Affairs-subsidiary |
Achat Informatif |
11,000 |
$0.44 |
$4.84K |
77,000 |
| 2021-04-01 |
Boudreau Bernard |
Director |
Achat Informatif |
12,500 |
$0.47 |
$5.86K |
148,000 |
| 2021-03-30 |
Boudreau Bernard |
Director |
Achat Informatif |
12,500 |
$0.40 |
$4.95K |
135,500 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
